Lucid Diagnostics Inc. (LUCD) Financials

LUCD Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 33.2 million 30.7 million
2023-06-30 42.5 million 27.4 million
2023-03-31 49.1 million 24.2 million
2022-12-31 32.5 million 9.5 million

LUCD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -8.8 million 1.3 million
2023-06-30 -7.0 million 1.4 million
2023-03-31 -7.1 million 3.2 million
2022-12-31 -4.5 million 3.7 million

LUCD Net Income

No data available :(

LUCD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 24.1 million - 1.6 million
2023-06-30 32.6 million - 1.8 million
2023-03-31 39.5 million - 1.9 million
2022-12-31 22.5 million - 2.0 million

LUCD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 41.9 million
2023-06-30 41.8 million
2023-03-31 41.0 million
2022-12-31 36.2 million

LUCD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 14000 1.6 million 4.3 million 3.8 million
2023-06-30 15000 1.8 million 3.8 million 4.0 million
2023-03-31 17000 2.3 million 6.5 million 4.1 million
2022-12-31 203000 2.4 million 5.5 million 5.0 million

LUCD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 783000 1.6 million
2023-06-30 159000 1.5 million
2023-03-31 446000 1.3 million
2022-12-31 112000 1.6 million

LUCD

Price: $0.69

52 week price:
0.67
1.85

Earnings Per Share: -1.26 USD

P/E Ratio: -0.89

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 72027

Market Capitalization: 44.2 million

Links: